CS
CBMG

Candriam SCA’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Candriam SCA’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-235,317
Closed -$4.33M – 829
2020
Q4 		$4.33M Hold
235,317
– – 0.03% 413
2020
Q3 		$4.32M Buy
+235,317
New +$3.96M 0.04% 374

Candriam SCA's CBMG Position: Q1 2021 in Review

Candriam SCA sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 235,317 shares — an estimated $4.33M sold.

Candriam SCA first reported a position in CBMG in Q3 2020 and held it in 2 quarters. The position peaked at $4.33M in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Candriam SCA reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Candriam SCA sold 235,317 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $4.33M.
  • Candriam SCA first reported a position in Cellular Biomedicine Group, Inc. in Q3 2020 and held it in 2 quarters.
  • Candriam SCA's Cellular Biomedicine Group, Inc. position peaked at $4.33M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.